English to Portuguese: Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs.a reference arm of intravenous CMF(cyclophosphamide, methotrexate and 5-fluorouraeil) as first-line therapy for advanced/metastatic breast cancer
Detailed field: Medical: Pharmaceuticals | |
Source text - English
Background : Oral capecitabine was evaluated in terms of overall response rate, safety, and tolerabihty as first-line therapy in women aged ≥ 55 years with advanced/metastatic breast
cancer. | Translation - Portuguese
Histórico: A capecitabina oral foi avaliada nos termos da taxa de resposta global, segurança e tolerabilidade como terapia de primeira linha em mulheres a partir de 55 anos inclusive, com câncer de mama avançado / metastático. |
Expertise